Use of first nucleotide change technology to determine the frequency of factor V Leiden in a population of Australian blood donors

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 8, 1997, Pages 491-495

  Pecheniuk, N M ^a   Marsh, N A ^a   Walsh, T P ^a   Dale, J L ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Activated protein C resistance; Factor V Leiden; First nucleotide change technology; Thrombophilia

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; DEOXYRIBONUCLEOTIDE;

ARTICLE; AUSTRALIA; BLOOD DONOR; COLORIMETRY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENE MUTATION; HETEROZYGOSITY; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TECHNOLOGY;

EID: 0031468431     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199711000-00002     Document Type: Article

References (17)

1. Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993; 82: 1989-1993.
2. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia study. Lancet 1993; 342: 1503-1506.
3. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-521.
4. Bertina RM, Koelman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated pn blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
5. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008.
6. Majerus PW. Bad blood by mutation. Nature 1994; 369: 14-15.
7. Press RD, Goodnight SH. Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C. West J Med 1995; 162: 450-452.
8. Greengard JS, Xu X, Gandrille S, Griffin JH. Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln-506 factor V. Thromb Res 1995; 80: 441-443.
9. Rabes JP, Trossaert M, Conard J, Samama M, Giraudet P, Boileau C. Single point mutation at Arg-506 of factor V associated with activated protein C resistance and venous thromboembolism: improved detection by PCR mediated site directed mutagenesis. Thromb Haemost 1995; 74: 1379-1380.
10. van der Locht LTF, Kuypers AWHM, Verbruggen BW, Lissen PCM, Novakova IRO, Mensink EJBM. Semi-automated detection of factor V mutation by allele specific amplification and capillary electrophoresis. Thromb Haemost 1995; 74: 1276-1279.
11. Zotz RB, Maruhn-Debowski B, Scharf RE. Mutation in the gene coding for coagulation factor V and resistance to activated protein C: detection of the genetic mutation by oligonucleotide ligation assay using a semi-automated system. Thromb Haemost 1996; 76: 53-55.
12. Dale JL, Timms P, Walsh T. Detection of a nucleic acid sequence or a change therein. PCT/AU90/00058 and Australian Patent No. 656514; 1990.
13. Higuchi R. Simple and rapid preparation of samples for PCR. In: Erlich HA, ed. PCR Technology. New York: Stockton Press, 1989; 31-38.
14. Dahlbäck B. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis 1994; 24: 139-151.
15. Rees DC, Cox M, Clegg JB. World distribution of Factor V Leiden. Lancet 1995; 346: 1133-1134.
16. Ma DDF, Aboud MR, Williams BG, Isbister JP. Activated protein C resistance (APC) and inherited factor V (FV) mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic. Aust NZ J Med 1995; 25: 151-154.
17. van Bockxmeer FM, Baker RI, Taylor RR. Premature ischaemic heart disease and the gene for coagulation factor V. Nature Med 1995; 1: 185.